Literature DB >> 18234547

Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity.

Nobuko Yoshida1.   

Abstract

Trypanosoma cruzi infection by oral route constitutes the most important mode of transmission in some geographical regions, as illustrated by reports on microepidemics and outbreaks of acute Chagas' disease acquired by ingestion of food contaminated with parasites from triatomine insects. In the mouse model, T. cruzi metacyclic trypomastigotes invade the gastric mucosal epithelium, a unique portal of entry for systemic infection. High efficiency of metacyclic forms in establishing infection by oral route is associated with expression of gp82, a stage-specific surface molecule that binds to gastric mucin and to epithelial cells. Gp82 promotes parasite entry by triggering the signaling cascades leading to intracellular Ca(2+) mobilization. T. cruzi strains deficient in gp82 can effectively invade cells in vitro, by engaging the Ca(2+) signal-inducing surface glycoprotein gp30. However, they are poorly infective in mice by oral route because gp30 has low affinity for gastric mucin. Metacyclic forms also express gp90, a stage-specific surface glycoprotein that binds to host cells and acts as a negative regulator of invasion. T. cruzi strains expressing gp90 at high levels, in addition to gp82 and gp30, are all poor cell invaders in vitro. Notwithstanding, their infectivity by oral route may vary because, unlike gp82 and gp30, which resist degradation by pepsin in the gastric milieu, the gp90 isoforms of different strains have varying susceptibility to peptic digestion. For instance, in a T. cruzi isolate, derived from an acute case of Chagas' disease acquired by oral route, gp90 is extensively degraded by gastric juice in the mouse stomach and this renders the parasite highly invasive towards target cells. If such an exacerbation of infectivity occurs in humans, it may be responsible for the severity of the disease reported in outbreaks of oral infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18234547     DOI: 10.1016/j.parint.2007.12.008

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  31 in total

1.  Role of GP82 in the selective binding to gastric mucin during oral infection with Trypanosoma cruzi.

Authors:  Daniela I Staquicini; Rafael M Martins; Silene Macedo; Gisela R S Sasso; Vanessa D Atayde; Maria A Juliano; Nobuko Yoshida
Journal:  PLoS Negl Trop Dis       Date:  2010-03-02

Review 2.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

3.  Oral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challenge.

Authors:  Matthew H Collins; Julie M Craft; Juan M Bustamante; Rick L Tarleton
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

4.  Molecular Epidemiology of Trypanosomatids and Trypanosoma cruzi in Primates from Peru.

Authors:  Esar Aysanoa; Pedro Mayor; A Patricia Mendoza; Carlos M Zariquiey; E Angelo Morales; Jocelyn G Pérez; Mark Bowler; Julio A Ventocilla; Carlos González; G Christian Baldeviano; Andrés G Lescano
Journal:  Ecohealth       Date:  2017-11-02       Impact factor: 3.184

Review 5.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

Review 6.  Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.

Authors:  Louisa A Messenger; Michael A Miles; Caryn Bern
Journal:  Expert Rev Anti Infect Ther       Date:  2015-08       Impact factor: 5.091

7.  Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells.

Authors:  Igor Cestari; Marcel I Ramirez
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

8.  Clinical outcomes of thirteen patients with acute chagas disease acquired through oral transmission from two urban outbreaks in northeastern Brazil.

Authors:  Claudilson J C Bastos; Roque Aras; Gildo Mota; Francisco Reis; Juarez Pereira Dias; Robson Silva de Jesus; Miralba Silva Freire; Eline G de Araújo; Juliana Prazeres; Maria Fernanda Rios Grassi
Journal:  PLoS Negl Trop Dis       Date:  2010-06-15

9.  Different parasite inocula determine the modulation of the immune response and outcome of experimental Trypanosoma cruzi infection.

Authors:  Diego C Borges; Natalia M Araújo; Cristina R Cardoso; Javier E Lazo Chica
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

Review 10.  Differential regional immune response in Chagas disease.

Authors:  Juliana de Meis; Alexandre Morrot; Désio Aurélio Farias-de-Oliveira; Déa Maria Serra Villa-Verde; Wilson Savino
Journal:  PLoS Negl Trop Dis       Date:  2009-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.